---
title: "Novavax Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295850280.md"
description: "Novavax Inc. (NVAX) shares rose 2.26% to $8.14, outperforming competitors Johnson & Johnson, Pfizer, and Merck on a favorable trading day. This marks the stock's third consecutive gain, though it remains 32% below its 52-week high of $11.97. Trading volume was slightly below the 50-day average."
datetime: "2026-08-13T21:29:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295850280.md)
  - [en](https://longbridge.com/en/news/295850280.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295850280.md)
generator: "portal-rs"
---

# Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) rallied 2.26% to $8.14 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.81% to 26,803.03 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.

This was the stock's third consecutive day of gains.

Novavax Inc. closed 32.00% short of its 52-week high of $11.97, which the company achieved on February 26th.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.47% to $262.08, Pfizer Inc. (PFE) rose 1.86% to $26.80, and Merck & Co. Inc. (MRK) rose 1.98% to $135.55.

Trading volume (3.5 M) remained 339,414 below its 50-day average volume of 3.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-13-26 1729ET

### Related Stocks

- [NVAX.US](https://longbridge.com/en/quote/NVAX.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Novavax to Participate in September Investor Conferences | NVAX Stock News](https://longbridge.com/en/news/297830700.md)
- [Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference](https://longbridge.com/en/news/298539070.md)
- [Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot](https://longbridge.com/en/news/298630872.md)
- [Novavax Inc. Stock Underperforms Thursday When Compared To Competitors](https://longbridge.com/en/news/298647510.md)
- [AVAX crypto eyes $8.65 – But first, Avalanche must hold THIS support](https://longbridge.com/en/news/298177979.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**